Cefepime Injection bulk supplier for pharma manufacturers

Cefepime Injection 250mg, 1000mg Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 250mg, 1000mg

Reference Brands: Maxipime (USA/EU)

Cefepime injection is used to treat bacterial infections in many different parts of the body. It belongs to the class of medicines known as cephalosporin antibiotics. It works by killing bacteria or preventing their growth. However, this medicine will not work for colds, flu, or other virus infections.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cefepime Injection? List it or send an offer →

Product Description:

Cefepime is a fourth-generation parenteral cephalosporin, and the generational label reflects a real difference: it combines the Gram-negative spectrum of third-generation agents, including anti-pseudomonal activity, with Gram-positive cover closer to first-generation cephalosporins. It is also more stable against AmpC beta-lactamases than third-generation agents, which matters against Enterobacter, Citrobacter and Serratia, where third-generation cephalosporins select for resistance during treatment.

It is used in febrile neutropenia, hospital-acquired pneumonia, complicated urinary and intra-abdominal infection, and is supplied as powder for injection, commonly at 500 mg, 1 g and 2 g.

A dosing caution worth carrying in labelling. Cefepime is associated with neurotoxicity — encephalopathy, myoclonus and non-convulsive status epilepticus — particularly in renal impairment where the dose has not been adjusted. It is frequently unrecognised because it presents as confusion in patients who are already unwell.

Sourcing notes. WHO classifies cefepime under Watch. Manufacture requires sterile powder-filling approval at the specific plant. Hospital tender volumes are significant, particularly in oncology and intensive care procurement, and generic supply is well established with competitive pricing.

Cefepime Injection — third party manufacturing & bulk supply

Cefepime Injection 250mg, 1000mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefepime Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefepime Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefepime Injection →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cefepime Injection is listed as Injection in 250mg, 1000mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefepime Injection is referenced against Maxipime (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.